Understanding diabetic neuropathy
- 14 December 1991
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 338 (8781) , 1496-1497
- https://doi.org/10.1016/0140-6736(91)92308-o
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Aldose reductase inhibition with imirestat ? effects on impulse conduction and insulin-stimulation of Na+/K+-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic ratsDiabetologia, 1991
- Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantationNeuroscience Letters, 1991
- A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathyDiabetologia, 1990
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990
- Effects of Pancreatic Transplantation on Diabetic NeuropathyNew England Journal of Medicine, 1990
- Polyols and myo-Inositol in Diabetic Neuropathy— of Mice and MenMayo Clinic Proceedings, 1989
- The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetesJournal of Molecular Medicine, 1988
- Pathogenesis and prevention of diabetic neuropathyDiabetes/Metabolism Research and Reviews, 1988
- Genetic and metabolic studies in diabetic neuropathyDiabetologia, 1984
- Acetylator phenotype in diabetic neuropathy.BMJ, 1977